Synceres Biosciences

About Synceres Biosciences

Synceres Biosciences is a high-tech company established in 2019 in Shenzhen, China, specializing in the research, development, and production of synthetic biological products. The company operates in the biotechnology sector, leveraging microorganisms as "cell factories" to create bioactive compounds. The firm was co-founded by Luo Xiaozhou, who is also a researcher at the Shenzhen Institute of Advanced Technology (SIAT). This relationship allows for the transfer of research achievements to Synceres Biosciences through an equity investment model, and the two have established a joint lab to share resources. The company is led by CEO Xibin Zhou. Starting with a small team, Synceres has grown to nearly 200 employees and has attracted significant funding. Synceres Biosciences employs a full-chain R&D and commercialization platform that integrates life sciences, information technology, and engineering automation. The company utilizes high-throughput synthetic biology technology to design gene combinations, regulate gene networks, and direct signal transduction pathways. This process enables the creation of new functional pathways or enzymes for manufacturing various active ingredients. An automated platform aids in the entire process, from DNA assembly and strain screening to product detection, which accelerates the design-build-test-learn (DBTL) cycle and strain iteration. The company's products include Ergothioneine, Gamma-aminobutyric acid (GABA), and Cannabigerol (CBG). The business serves a wide range of industries, including biomedicine, health food, industrial daily chemicals, new energy, and new materials, helping clients to upgrade their own industrial processes. The company is committed to green production, using renewable resources and optimizing processes to reduce energy consumption and emissions. Synceres has received backing from investors such as Shenzhen Capital Group, Bloomage International, and Co-Stone Capital. Keywords: synthetic biology, microbial cell factories, bioactive compounds, gene synthesis, metabolic engineering, R&D platform, industrial biotechnology, biomedicine ingredients, health food additives, green production, fermentation, automation platform, strain engineering, Ergothioneine, GABA, CBG, gene regulation, enzyme production, sustainable manufacturing, biochemicals